United Therapeutics Corporation
Christopher Patusky (Director) sells UTHR shares
AI-generated summary
Director Christopher Patusky exercised options for 1,210 shares of Common Stock at an average price of $132.30, worth $160,083. Christopher Patusky then sold 1,210 shares of Common Stock at an average price of $580.00, worth $701,800. After these transactions, Christopher Patusky directly held 2,140 shares of Common Stock.
Key facts
- Insider
- Christopher Patusky · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +1,210 | $132.30 | $160,083.00 | 3,350 | Direct |
| Nov 9, 2026 | S · open-market sale | −1,210 | $580.00 | $701,800.00 | 2,140 | Direct |
| Nov 9, 2026 | M · exercise or conversion of a derivativeStock Option | −1,210 | $0.00 | $0.00 | 3,000 | Direct |
Footnotes
- F1 The Form 4 filed by the Reporting Person on July 23, 2026 incorrectly reported the Amount of Securities Beneficially Owned following Reported Transaction in Column 5 of Table I. The correct number should have been 2,140.
More UTHR filings
- 4
Filed Nov 10, 2026
- 4
Filed Nov 10, 2026
- 4
Filed Nov 9, 2026
- 144
Filed Nov 9, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.